European Research Group on Outcomes of Surgical Treatment of Infective Endocarditis
NCT ID: NCT07108803
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
2500 participants
OBSERVATIONAL
2025-06-01
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis
NCT05791357
Etiology of Endocarditis in Negative Blood Cultures
NCT02816307
Diagnosis and Bacterial Identification of Periprosthetic Joint Infection With Microbial-ID
NCT05320354
Personalized Medicine in Patients With Infective Endocarditis
NCT04838938
The Inselspital Surgical Cohort Study
NCT04096885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To create a European multicenter retrospective database including a large number of patients undergoing surgical treatment for infective endocarditis (IE).
* To perform epidemiologic analyses of IE-patients and involved pathogens.
* To find independent predictors of early post-operative death.
* To test ALL the scoring systems specifically developed to predict early death after surgery for infective endocarditis.
* To devise a specific risk score for early postoperative death.
* To explore early and late outcomes of these very difficult patients in order to establish optimal indications, techniques and timing of surgery.
* To carry out a number of sub-analyses concerning the demographic parameters and variable clinical presentation of patients, type and severity of cardiac structural involvement, adopted valve prostheses and surgical techniques, and different involved microbiologic agents.
* To lay experiential foundations of a prospective database on the topic.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI)
UNKNOWN
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giuseppe Gatti
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiac Surgery Unit - ASUGI
Trieste, TRIESTE, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
386_2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.